Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 682M | 665M | 646M | 617M |
Cost of revenue | 158M | 157M | 155M | 148M |
Gross profit | 524M | 508M | 491M | 469M |
Operating expense | ||||
Research & development | 157M | 158M | 164M | 163M |
Selling general and admin | 348M | 366M | 346M | 353M |
Other operating expenses | — | — | — | — |
Operating income | 19M | -16M | -19M | -47M |
Non operating interest income | ||||
Income | 24M | 26M | 29M | 27M |
Expense | 1M | 1M | 1M | 2M |
Other income expense | -11M | 16M | 3M | — |
Pretax income | 31M | 25M | 12M | -22M |
Tax provision | 8M | 9M | -17M | 18M |
Net income | 23M | 16M | 29M | -40M |
Basic EPS | — | 0.1 | 0.2 | -0.2 |
Diluted EPS | — | 0 | 0.2 | -0.2 |
Basic average shares | — | 193.5M | 191.6M | 190.3M |
Diluted average shares | — | 194.0M | 198.3M | 190.3M |
EBITDA | 67M | 32M | 31M | 1M |
Net income from continuing op. | 23M | 16M | 29M | -40M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |